High dosage of Prostate-Specific Antigen (PSA) in a patient after radical prostatectomy and without clinical evidence to support tumor recurrence: case report. (2021). Research, Society and Development, 10(13), e93101321104. https://doi.org/10.33448/rsd-v10i13.21104